$11.49
0[0.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$11.28
-0.2100[-1.83%]
| Open- | Close- |
| Vol / Avg.0 / 54.963K | Mkt Cap721.816M |
| Day Range- - - | 52 Wk Range9.760 - 15.000 |
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%
Bioceres Crop Solutions Stock (NASDAQ:BIOX), Key Statistics
Bioceres Crop Solutions Stock (NASDAQ: BIOX) analysis, key statistics.
Valuation Measures
Enterprise Value
918.3M
Trailing P/E
43.22
Forward P/E
25.25
PE Ratio (TTM)
43.22
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.72
Price / Book (mrq)
2.43
Price / EBITDA
13.64
Enterprise Value / EBITDA (TTM)
17.36
Earnings Yield
2.31%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.72
Tangible Book value per share
0.2
Total Liabilities (Quarterly)
494M
Total Assets
824.1M
Total Liabilities
494M
Profitability
Net income Growth
- -
Gross Margin
38.68%
Net Margin
-3.63%
EBIT Margin
4.87%
EBITDA Margin
4.87%
Operating Margin
4.87%